
















































A Series of Population-based Epidemiological Studies on Subclinical
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Abstract The population trend in cardiovascular risks in Japan has changed remarkably over the past few decades. To
examine whe血er such trend has been translated in subclinical atherosclerosis, we have been conducting series of
population-based epidemiological study on subchnical atherosclerosis in Shiga, Japan. We will briefly describe the outline
of those epidemiological studies and some of our notable published findings as well as future direction of those studies.
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INTRODUCTION
Scope of the epidemiological study
To conduct our research, we have made use of
epidemiological studies. Epidemiology is often defined as
"the study of the distribution and determinants of
health-re一ated states or events in specified populations
and the application of this study to control of health
problem. [1]　Not surprisingly,　the scope of
epidemiological studies differs from that of clinical trials.
In general, the target populations for clinical trials are
groups of patients with certain pre-determined features
that are characteristic of the disease or disorder of
interest. The main purpose ofa clinical trial is to evaluate
the efficacy, as well as the adverse effects of the
administered intervention,　such as pharmaceutical
treatment or surgery. Typically, the ultimate goal in
conducting such trials is to establish an effective
treatment for the ailing patient.
In contrast, the main objective of epidemic-logical
studies is "to identify the etiology or the cause of disease
and the risk factors-that is, factors that increase a
person's risk for a disease,"【2] usually by observing the
frequency and the distribution of the disease at a
p pulat on level. This is carried out by evaluating effects
of certain exposures ( moking, alcohol drinking, and diet,
for exampl ) over outcomes (death, disease, or other
endpoints such as weigh  change, etc) and determining if
there is a cau al relationship between the two. Its ultimate
goal is to bring aboutprevention ofa disease and improve
the overall heal h t a population level. Epidemiologists
often study a "sample" (i.e. a group of people) from a
general population (i.e. a population-based study) in order
to ensure the s udy findings are applicable to "ordinary"
peopl  rather than being exclusive to "patients".
Within this frame of mind, our department has been
conducting mul iple population-based epidemiological
studies in the subject of cardiovascular disease
prevention.
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The Seven Countries Study and more recent
trends
The Seven Countries Study is a milestone of
epidemiological studies in the field of cardiovascular
disease. Ancel Keys at the University of Minnesota, and
his colleagues in seven countries, posed the hypothesis
that differences among populations in the frequency of
heart attacks and stroke would occur in some orderly
relation to lifestyle, particularly composition of the diet,
and especially fat content within the diet. To test this
theory, surveys were carried out from 1958 to 1964 in
populations of men aged　40-59　years in eighteen
populations in seven different countries. A follow-up of
deaths in the cohort has been maintained to the present
day.[3] This study was the first to explore associations
among diet and risk; clearly demonstrating the causal
relationship between serum cholesterol level and risk of
coronary heart disease, even among different ethnic
groups.[4]
Among the Seven Countries Study populations,
aged 40-59 years in the late 1950s to the early 1960s, the
mean cholesterol level for the Japanese sample was
around 165 mg!dL and the mean for the United States
(US) sample was 240 mg/dL[4]- a difference of about 75
mg/dL between these two populations. However, when the
post World War II generation aged, the differences in
cholesterol levels between Japan and US has diminished:
the levels being increased in Japan, and decreased in
US.[5] Some other cardiovascular risk factors, such as
smoking and high blood pressure, have remained less
favorable in Japan compared to US, although these two
particular risk factors among Japanese population have
improved over the past few decades. Figure 1 shows more
recent results of the two national surveys, one conducted
in Japan and the other in US. It illustrates how the levels
of some cardiovascular risk factors are close or even less
favorable in Japan compared to US.
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Figure 1. Comparison of Cardiovascular Risk Factors
among those aged 30 to 40s between US and Japan.
Despite such trends in risk factors between the two
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countries, actual coronary heart disease (CHD) mortality
has remained lower in Japanese populations compared to
US populations.[6] This gap ofa similar CHD risk profile
with less actual CHD mortality in Japan, has drawn the
atten ion and interest of many research groups. This gap
s sometimes call the "Japanese paradox".[5] In order to
examine whether similar gap is observed in subclimcal
atherosclero is among middle-aged adults in Japan and
US, we began the f rst set of our cardiovascular
epidemiological studies: Hthe ERA JUMP　星Iectron-Beam
Tomog aphy and星isk Assessment among ∠apanese and US
Men in theとost World War IIBirth Cohort) study."
STUDY OUTLINES
Figur 　2 is n utl ne for the progression of our
cardiovascular epidemio ogical studies, beginning with
the ERA JUMP stu y and leading to the combined studies.
ERA JUMP
In brief, ERA JUMP is an international collaborative
study, mod led after the Seven Countries Study, where the
sample population was 40 to 49 year-old men. Our group
at Shiga Universi y of Medical Science (SUMS) has
served as a Japanese Center for the study and enrolled
300 men aged 40 to 49 y ars by random selection from
th  residents r gistry in Kusatsu City, Shiga, Japan. The
registry contained nformation on name, birth date, and
address of all residents in the city. Commencement of the
su vey at our site was in 2002 and its completion was in
2004. Furth r detai s of the ERA JUMP study will be
discussed later.
ACCESS
In the following year (2005), our group alone expanded
the ERA JUMP study to include those in their 50s. Shortly
afte ward , a co tract research study on LpPLA2
(lipoprotein-associated phospholipase A2)　with a
pharmaceutical company had come into fruition. The
target population of this contract study was similar to the
expanded study, and we were thus able to integrate both
studies into one population study. The integrated research
was named　"Atherosclerosis Case-Control and
Epidemiology of宣ubclinical星fate" (ACCESS) Study. As
the name indicates, this study population consists of
approximately 600 cases (i.e. those with CHD), and 1200
controls (those without CHD), both groups aged 40-79
years, a much wider age range than the ERA JUMP study.
These two populations were surveyed from 2005 through
2008 with almost the exact same methods as used in the
ERA JUMP study.
Follow-up Studies
In 2008, we start d the follow-up survey for ERA JUMP,
and completed it in 2009. The follow-up survey for the
control participants of ACCESS has been initiated m 2009
and is presently ongoing. We have renamed the study on
this particular subgroup (approximately 1200　control
participants of the ACCESS study)　as　宣higa
Epidemiological　星tudy of　墨ubclinical Atherosclerosis
(SESSA). Recently, we have added a cognitive function
test (Cognitive Assessment Screening Instrument: CASI
[7]) to our survey. Furthermore, we have started including
brain magnetic resonance imaging (MRI) in this study
through collaborations with the Department of
neurosurgery and the Molecular Neuroscience Center at
SUMS. Ageing is one of the major recent trends seen
worldwide.[8] Without doubt, cognitive decline will
become more prevalent as our population ages. Increasing
evidence has shown that cognitive decline and
atherosclerosis are more closely related than previously
thought.[9,10] CASI is shown to capture the early phase
of cognitive decline.[11] MRI can detect subclinical
atherosclerosis as well as other degenerative changes in
the brain. By adding these two modalities to our initial
measures of subclinical atherosclerosis, we will obtain
more methods in assessing pathophysiology of cognitive
decline. Thus, we aim to elucidate links between
raZi-clinical atherosclerosis and mild cognitive
impairment in order to understand factors that influence
cognitive decline.




























Figure　2. Outline of the series of epidemiological
studies and their progression.
FINDINGS
Key findings ERA JUMP
The ERA JUMP study was the first international
epidemiological study to assess measures of subclimcal
atherosclerosis in population-based cohorts using
standardized methods. Primary aims of this study are: (1)
to test the null hypotheses that there are no differences in
the prevalence of coronary artery calcification (CAC) and
39
levels of ca otid intima-media thickness (IMT) among
men aged　40　to　49　years, sampled from general
populations with different CHD mortality risk despite
very similar traditional risk factor profiles.
Population-based samples of Caucasians in Allegheny
County, P nn y vania, U.S. and of Japanese m Kusatsu,
Shig , Japan, as well as of Japanese Americans (the
offspring of the participants m the Honolulu Heart
Program) were obtained. The ERA JUMP Study has also
examined population-based samples of 302 Korean men
aged　40-49 in Ansan, South Korea,[12,13] and 107
African Am rican men aged 40-49 in Allegheny County,
Pennsylvania, U.S.[14]
The distribut on patterns of cardiovascular risk
factor observed in the ERA JUMP study were consistent
with hose found in the two National Surveys, as
mention earlier. Both US-Caucasians and Japanese in
Jap n had similar levels of mean LDL-cholesterol: 134
mg!dL for he Japa ese sample and 135mg/dL for the
US-Caucasian sample. Except for levels of obesity and
HDL-chol terol, the Japanese sample population had less
favorable CHD risk factor profiles compared to
US-Caucasians: prevalence of hypertension (24% versus
15%　for Japanes  v rsus US-Caucasian samples,
re pective y), prevalence in current smoking (47 %
versus 7%), f st g glu ose level (106 mg/dL versus 101
mg/dL), prevalence of diabetes mellitus (5.0%　versus
3.2%).【15] Interestingly, however, our study shows lower
level of coronary artery calcification (CAC), a good
measure of atherosclerotic burden of coronary artery, in
Japanese compared to US-Caucasians (Figure　3).[16]
This parallels the "Japanese paradox": Japanese in Japan
having significantly lower levels of CAC than
US-Caucasians despite similar or even less favorable risk
factor levels with US-Caucasian.
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Figure 3. The distr bution of coronary calcium score
(Agat ton sc e) in US-Caucasian men and Japanese
men in Japan of the ERA JUMP study in 2002-2004
(adopted from Sekikawa A et al. Int. J. Epidemiol.
2005:34:1 73-1 79)
As a next step, we compared the prevalence ofCAC
(defined as Agatston score≧ 10) and carotid IMT, both of
which are measures of subclmical atherosclerosis, among





























IMT : average of 8 artery measures (right and
left of the foblV'ing four locations)'the
common carotid (proximal, distal), the carotid
bulb (distal), the internal carotid (distal)
Figure 4. Prevalence of coronary artery calcification
(CAC) and carotid intima-media thickness (IMT)
among three sample populations in ERA JUMP:
Japanese, US-Caucasians, and Japanese Americans
(adopted from Sekikawa et al. J Am Coll Cardi01 2008;
52:41 7)
In an attempt to uncover the possibility of genetic
factors contributing to the Japanese paradox, we have
included Japanese Americans in Hawaii. These
individuals should have a similar genetic background with
Japanese in Japan as they are offspring of second or third
generation of the Japanese who migrated to Hawaii. In
Figure　4, Japanese in Japan have significantly lower
levels of atherosclerosis in the coronary artery and in the
carotid arteries (as measured by CAC and IMT,
respectively) than US-Caucasians or Japanese Americans.
It is unlikely that the Japanese paradox is a result of
genetic factors as Japanese Americans have higher CAC
and IMT levels than Japanese in Japan. In another attempt
to explain this paradox, we have explored both
conventional and novel risk factors in the ERA JUMP
study, such as C-reactive protein, fibnnogen, PAI-1,
cytokines (IL-4, IL-8, IL-10, TNF-alpha) and so
on.[17-25] Based on our analyses, none of these factors
far were able to explain the difference in
atherosclerosis between Japanese in Japan and U.S.
populations. The results strongly suggest that it is
unlikely that the differences in atherosclerosis between
Japan and the U.S. are primarily a function of genetic
differences, especially given the observed differences
between the Japanese in Japan and Japanese Americans in
Honolulu.
m
One strong candidate we are currently considering
is the dietary intake of marine-derived n-3　fatty acid.
J pan is known as a country where its rate of fish
consumption is one of the highest in the world.[26]
Rece t studies in Japan have revealed that pharmaceutical
supplementation or dietary intake of marme-denved n-3
fatty acids is significantly associated with a reduced risk
of nonfatal coronary events.[27,28]　Furthermore,
multi-levels of evidence suggest a cardio-protective effect
of serum n-3 fatty acids.【29] Thus, we evaluated serum
marine n-3　fatty acids and their association with
subclinical atherosclerosis. We have found that: serum
levels of marine n-3　fatty acids are much higher in
Japanese than in Caucasians and Japanese Americans; the
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Figure　5.　Cross-sectional association between
i tima-inedia thickn s (IMT) of carotid artery and
serum level of mar ne-derived n-3　fatty acid
(constructed from Sekikawa et al. J Am Coll Cardi01
2008; 52:417)
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Figure 6. Cross-sectional association between coronary
artery calcification (CAC) and serum level of
marin -derived n-3　fatty acid (constructed from
Sekikawa et al. JAm Coll Cardiol 2008; 52:417)
higher levels of marine n-3fatty acids in Japanese in
Japan significantly contribute to the differences in the
levels of subclinical atherosclerosis between Japanese in
Japan and Caucasians (Figures 5, 6.)[15]
Other findings from ERA JUMP
The ERA JUMP study has lead to many other important
findings. To give some brief examples, we have found
that: Japanese men, on average, have larger area of
visceral adipose tissue than US Caucasian men, even in
the cases of same waist circumference level.[17] This
observation may support the hypothesis that East Asians
are more vulnerable to diabetes mellitus compared to
Caucasians, when gaining weight, due to their stronger
tendency to accumulate ectopic visceral fat[30】 (known as
"adipose tissue overflow hypothesis"[31]). In other study,
we have first reported that the Japanese had a J-shaped
association with CAC,[32] which is parallel to risk of
CHD. Furthermore, we have observed a positive
association between CAC and serum level of cholesteryl
ester transfer protein (CETP),[33] a key protein in the
reverse-cholesterol transport.
FUTURE DIRECTION
The ACCESS/SESSA study is an extension of the ERA
JUMP study. We have recently started reporting the
findings from the cohort study (SESSA). We will continue
to work on elucidating the factors that influence
prevention and progression of subclinical atherosclerosis
by exploring nutritional factors, including alcohol
consumption, dietary fatty acids intake, presence of
biomarkers (including CAC, IMT, and ectopic fat tissues),
anthropometric measures, as well as genetic factors.
Furthermore, because stroke remains more prevalent than
CHD in Japan, we will extend our focus to atherosclerotic
and degenerative changes in the brain, allowing for a
broad range of cardiovascular disease study. The
collection of data on cognitive function tests and brain
MRI is ongoing. Long term follow-up studies that
ascertain the "hard" endpoints, such as CVD events and
death, will be in our scope in the near future.
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Image assessment of coronary a也erosclerotic lesions
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Clinical research for atherosclerotic disease and the further progress
Basic research for cerebral aneurysm and medical treatment
Toshihiro YOKOI , Makoto SAITO , Yayoi YOSHIMURA and Kazuhiko NOZAKI
Department of Neurosurgery, Shiga University of Medical Science
Abstract Cerebral aneurysmal subarachnoid hemorrhage is devastating desease for human living, however, effective medical treatment
has not been established. Recent reports have shown that regression of some inflammation related mediator have protective effects in
experimental cerebral aneurysm models. We corroborated the effectiveness of some pleiotrophic effect that downregurate inflammation
related mediator mandate to form cerebral aneurysm. We show here mainly laboratory investigation which is deeply related to clinical
research for atherosclerotic disease.
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